Moa Fransson
Direttore/Membro del Consiglio presso ENZYMATICA AB
Profilo
Moa Fransson is the founder of Bioflow Systems AB.
She is currently the Chief Executive Officer of Genagon Therapeutics AB and Director at Enzymatica AB.
She holds a doctorate degree from the University of Uppsala.
Posizioni attive di Moa Fransson
| Società | Posizione | Inizio |
|---|---|---|
| ENZYMATICA AB | Direttore/Membro del Consiglio | 01/05/2022 |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Amministratore Delegato | 01/12/2019 |
Precedenti posizioni note di Moa Fransson
| Società | Posizione | Fine |
|---|---|---|
| Bioflow Systems AB | Fondatore | - |
Formazione di Moa Fransson
| University of Uppsala | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENZYMATICA AB | Health Technology |
| Aziende private | 2 |
|---|---|
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
| Bioflow Systems AB |
- Borsa valori
- Insiders
- Moa Fransson
